News

View all
Thumbnail

J&J’s Stelara wins US nod for Crohn’s

US regulators have expanded the reach of Johnson & Johnson group Janssen Biologics' psoriasis blockbuster Stelara to include the treatment of patients with Crohn's disease.

27th September 2016

Thumbnail

Novartis bags three new approvals for Ilaris

Novartis has picked up three new indications for its anti-inflammatory Ilaris in the US, allowing its use to treat three rare and distinct types of Periodic Fever Syndromes.

27th September 2016

Thumbnail

MSD, Wayra launch new digital accelerator programme

MSD and Wayra UK have unveiled the next focus of their digital health innovation accelerator programme, calling for "radical solutions" to improving the treatment and care of patients with diabetes and helping cancer patients self-manage recovery.

27th September 2016

Web Exclusives

View all
Thumbnail

Making precision medicine work

Cancer Research UK's head of precision medicine on how the charity is preparing the NHS for this paradigm shift in treatment

Thumbnail

Inclusion criteria

With new research showing that pharma senior teams are less diverse than comparable industries, companies could do more to instil a culture of inclusion

Thumbnail

Now it's personal

Putting the right tools in patients' hands could personalise treatment and improve health across the board

Thumbnail

Industry roundup – 21 July

Biobank banks genes of long-lived Sardinians; stem cell therapies face commercial challenges; VBI moves forward with Zika Vaccine

Thumbnail

The clinical trial of the future

The industry is approaching a new age of trials that are streamlined, connected and more engaged with the patient – but only if pharma can embrace the changes

Thumbnail

On target?

Precision medicine is fundamentally changing how we treat patients, but is it too early to get excited about this burgeoning area?

Thumbnail

Higher education

Pharma-sponsored medical education has always been about much more than just education, yet with greater transparency, changing learning styles and increased influence of expert patients, what does the future hold for pharma's wider interactions with healthcare professionals?

Thumbnail

On the front line

NHS vanguard sites are offering a fresh approach to service design and creating a blueprint for the future but what impact will they have on pharma?

Thumbnail

Under the hammer

Are reverse auctions the best way to procure marketing services?

Thumbnail

Show, don’t tell

If pharma really wants to be patient-centric, it needs to show it through its brand message

Thumbnail

Track record

In the not-too-distant future, we will all be living in an ongoing clinical trial, where sensors track our lives and stream our health data directly to our electronic health records

Thumbnail

Community spirit

Online communities offer direct contact with patients, healthcare professionals and other stakeholders, but is pharma making the most of this valuable resource?

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download